Skip to main content
Clinical Trials/IRCT20190716044230N1
IRCT20190716044230N1Not yet recruitingPhase 3

Analgesic Efficacy of Ketoprofen Transdermal Patch Versus Ibuprofen Tablet on Post-Endodontic Pain in Patients with Irreversible Pulpitis – A Randomized Clinical Trial

Shahid Beheshti University of Medical Sciences0 sites54 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
54

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Patients whom their physical status is classified as ASA I
  • Mandibular first/second molar diagnosed as irreversible pulpitis with moderate to severe pain
  • Positive response to electric pulp test, lingering pain to cold test which validate the diagnosis of irreversible pulpitis for each tooth

Exclusion Criteria

  • Having any systemic disorders, gastrointestinal disease or allergy which interfere with NSAIDS
  • Allergy to local anesthesia drugs or sulfite
  • Teeth that are not appropriate to be restorated or teeth with severe periodontal disease which are not suitable for endodontic treatment
  • Patients with swelling or fistula
  • Using any analgesic drug in the past 12 hours
  • Spontaneous pain which requires emergency treatment
  • Not being able to give informed consent or not being able to read and write
  • Pregnant or breastfeeding women
  • Exit criteria include disability (for any reason) in patient's fallow-up, inappropriate endodontic treatment or a two visit treatment and using other analgesics along with the study drugs.

Investigators

Similar Trials

Analgesic Efficacy of Ketoprofen... | Clinical Trial